Cover Image

Supplementary Materials for "Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution" (Journal of Virology)

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Foster, Charles
Format:	Recurso digital
Language:	English
Published:	Zenodo 2025
Subjects:	Virology Evolution
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Integrating Fréchet distance and AI reveals the evolutionary trajectory and origin of SARS‐CoV‐2
by: Anyou Wang
Published: (2024)

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
by: Nicolas Capelli, et al.
Published: (2024)

Sexual Dimorphism in Systemic Inflammatory Responses to Femur Fracture in Mice Infected With SARS‐CoV‐2‐Like Virus
by: Matthew D. Patrick, et al.
Published: (2025)

The controversy of SARS‐CoV‐2 integration into the human genome
by: Laith AL‐Eitan, et al.
Published: (2024)

Dispersal history of SARS‐CoV‐2 in Galicia, Spain
by: Pilar Gallego‐García, et al.
Published: (2024)

Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown
by: Frank T. Aboagye, et al.
Published: (2024)

Genomic Surveillance of SARS‐CoV‐2 in Rio de Janeiro (2020–2021): Temporal Distribution of Viral Variants During the Early Pandemic Genomic Surveillance of SARS‐CoV‐2 in Brazil
by: Priscila de Jesus Fajardo, et al.
Published: (2026)

SARS‐CoV‐2 Infection Among Children in Rondônia, Western Brazilian Amazon
by: Gil Guibson Mota Amaral, et al.
Published: (2025)

Parental Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Predominates Over Coinfected SARS‐CoV‐2 Delta, Producing Less Lethal Variants in a Long‐Term Replication Mouse Model
by: Kyeongbin Baek, et al.
Published: (2024)

Impact of High‐Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS‐CoV‐2 Infection: VA CoronavirUs Research and Efficacy Studies‐1 (VA CURES‐1)
by: Edward N. Janoff, et al.
Published: (2025)

Heterogeneous Evolution Among SARS‐CoV‐2 Genes and Variants of Concern
by: Luis Daniel González‐Vázquez, et al.
Published: (2025)

Research progress in Fc‐effector functions against SARS‐CoV‐2
by: Rongyuan Gao, et al.
Published: (2024)

The mutation point of view of the SARS‐CoV‐2 HV.1 lineage
by: Alessandra Ciccozzi, et al.
Published: (2024)

Large‐Scale Screening of CD4+ T‐Cell Epitopes From SARS‐CoV‐2 Proteins and the Universal Detection of SARS‐CoV‐2 Specific T Cells for Northeast Asian Population
by: Yu Zhao, et al.
Published: (2025)

A mouse xenograft long‐term replication yields a SARS‐CoV‐2 Delta mutant with increased lethality
by: Dongbum Kim, et al.
Published: (2024)

Co‐Infection With Hepatitis E Virus and SARS‐CoV‐2 in a Lymphoma Patient
by: Yacine Boucetta, et al.
Published: (2025)

Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection
by: Chang‐Yong Choi, et al.
Published: (2024)

Anti‐SARS‐CoV‐2 Antibodies in Long‐COVID—Markers of Protection or Elevated Risk? A Systematic Review
by: Sylvia Mink, et al.
Published: (2025)

Performance of Long‐Read Single‐Molecule Real‐Time Sequencing for SARS‐CoV‐2 Genotyping in Clinical Samples
by: Pauline Trémeaux, et al.
Published: (2025)

Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
by: Matthew S. Durstenfeld, et al.
Published: (2024)

Development and Validation of a Rapid and Sensitive Lateral Flow Immunoassay for the Detection of SARS‐CoV‐2
by: Abdenacer Benchrifa, et al.
Published: (2026)

SARS‐CoV‐2 Productively Infects Human Hepatocytes and Induces Cell Death
by: Chunkyu Ko, et al.
Published: (2025)

Proteomic and Phosphoproteomic Profiling of Kidney in Rhesus Macaques With SARS‐CoV‐2 Infection
by: Yizhuo Tian, et al.
Published: (2025)

Cigarette Smoke Deteriorates SARS‐CoV‐2 Infection‐Induced Lung Injury
by: Rui Chen, et al.
Published: (2025)

Maternal Vaccination and Protective Immunity Against SARS‐CoV‐2 Infection in Pups
by: Kunpeng Liu, et al.
Published: (2025)

The abortive SARS‐CoV‐2 infection of osteoclast precursors promotes their differentiation into osteoclasts
by: Franco Sviercz, et al.
Published: (2024)

Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge
by: Akshay Binayke, et al.
Published: (2024)

Genetic Conservation and Diversity of SARS‐CoV‐2 Envelope Gene Across Variants of Concern
by: Benjamin M. Liu, et al.
Published: (2025)

Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS‐CoV‐2 Infection
by: Soraya Mezouar, et al.
Published: (2025)

Analytical Performance of a Novel Nanopore Sequencing for SARS‐CoV‐2 Genomic Surveillance
by: Mulatijiang Maimaiti, et al.
Published: (2024)

The Blood‐Cerebrospinal Fluid Barrier as a Potential Entry Site for the SARS‐CoV‐2 Virus
by: Peter Solár, et al.
Published: (2025)

COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters
by: Laure Chaput, et al.
Published: (2024)

Characterization of the Pathogenic Features of Multiple SARS‐CoV‐2 Pandemic Strains in Different Mouse Models
by: Huize Sun, et al.
Published: (2024)

Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor
by: Kuo‐Chuan Hung, et al.
Published: (2024)

Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin
by: Hu Zhang, et al.
Published: (2024)

CRISPR‐Cas system: A promising tool for rapid detection of SARS‐CoV‐2 variants
by: Jing Li, et al.
Published: (2024)

Specific long‐term changes in anti‐SARS‐CoV‐2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines
by: Sebastian Reinig, et al.
Published: (2024)

Long‐Term Sequelae of COVID‐19: A Systematic Review and Meta‐Analysis of Symptoms 3 Years Post‐SARS‐CoV‐2 Infection
by: Masoud Rahmati, et al.
Published: (2025)

Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein
by: Yezi Wu, et al.
Published: (2025)